Search Result "Anti-CD3"


Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma

Journal: Current Drug Targets
Volume: 10 Issue: 2 Year: 2009 Page: 104-109
Author(s): A. E. Frankel, S. L. Zuckero, A. A. Mankin, M. Grable, K. Mitchell, Y. J. Lee, D. M. Neville, J. H. Woo

Meta-Analysis

Narrative Review of Anti-CD3 Antibody and Anti-CD20 Antibody:Immunotherapeutic Strategies to Treat and Prevent Type 1 Diabetes

Journal: Recent Advances in Inflammation & Allergy Drug Discovery
Volume: 17 Issue: 1 Year: 2023 Page: 64-70
Author(s):

Clinical Update on the Use of Immuno Modulators (antiCD3, GAD, Diapep277, Anti-IL1) in Type 1 Diabetes

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 3224-3228
Author(s): Paolo Pozzilli, Chiara Guglielmi, Daria Maggi, Angela Carlone, Raffaella Buzzetti, Silvia Manfrini

Systematic Review Article

Safety and Efficacy of Teplizumab for Treatment of Type One Diabetes Mellitus: A Systematic Review and Meta-analysis

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 21 Issue: 0 Year: 2021 Page: 1-12
Author(s): Anas Zakarya Nourelden,Alaa Ahmed Elshanbary,Loalo'a El-Sherif,Amira Yasmine Benmelouka,Hagar Ismail Rohim,Sara Kamel Helmy,Merhan Kamal Sayed,Ammar Ismail,Ahmed Said Ali,Khaled Mohamed Ragab,Mohamed Sayed Zaazouee

Research Article

The Study of Partial Microenvironment Pre- and Post-microwave Ablation in Rabbit Peripheral Pulmonary VX2 Tumors

Journal: Current Medical Imaging Reviews
Volume: 14 Issue: 6 Year: 2018 Page: 938-946
Author(s): Jin Xing,Wen He,Yi-Wen Ding,Yang Li,Yan-Dong Li

Review Article

Journey of Teplizumab: A Promising Drug in the Treatment of Type 1Diabetes Mellitus

Journal: Current Diabetes Reviews
Volume: 20 Issue: 0 Year: 2024 Page: 1-8
Author(s): Debashree Debasish Das,Pooja A Chawla

Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy

Journal: Current Gene Therapy
Volume: 10 Issue: 2 Year: 2010 Page: 77-90
Author(s): John S. Bridgeman, Robert E. Hawkins, Andreas A. Hombach, Hinrich Abken, David E. Gilham

New Insights of CTLA-4 into Its Biological Function in Breast Cancer

Journal: Current Cancer Drug Targets
Volume: 10 Issue: 7 Year: 2010 Page: 728-736
Author(s): H. Mao, L. Zhang, Y. Yang, W. Zuo, Y. Bi, W. Gao, B. Deng, J. Sun, Q. Shao, X. Qu

Review Article

Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives

Journal: Current Medicinal Chemistry
Volume: 24 Issue: 28 Year: 2017 Page: 3054-3067
Author(s): Lazaros I. Sakkas,Athanasios Mavropoulos,Dimitrios P. Bogdanos

Therapeutic Targets for the Prevention of Type 1 Diabetes Mellitus

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 5 Issue: 2 Year: 2005 Page: 227-236
Author(s): N. Singh, J. P. Palmer

Previous   Next

Go To   Results 1 - 1 of 1462

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy